These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1123 related articles for article (PubMed ID: 20588177)
1. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria. Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177 [TBL] [Abstract][Full Text] [Related]
2. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas? Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499 [TBL] [Abstract][Full Text] [Related]
3. Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration. Mariño-Enríquez A; Hornick JL; Dal Cin P; Cibas ES; Qian X Cancer Cytopathol; 2014 Feb; 122(2):128-37. PubMed ID: 24227706 [TBL] [Abstract][Full Text] [Related]
4. Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma. Chung L; Lau SK; Jiang Z; Loera S; Bedel V; Ji J; Weiss LM; Chu PG Am J Surg Pathol; 2009 Nov; 33(11):1594-600. PubMed ID: 19574885 [TBL] [Abstract][Full Text] [Related]
5. Well-differentiated and dedifferentiated liposarcomas with prominent myxoid stroma: analysis of 56 cases. Sioletic S; Dal Cin P; Fletcher CD; Hornick JL Histopathology; 2013 Jan; 62(2):287-93. PubMed ID: 23020289 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors. Thway K; Flora R; Shah C; Olmos D; Fisher C Am J Surg Pathol; 2012 Mar; 36(3):462-9. PubMed ID: 22301498 [TBL] [Abstract][Full Text] [Related]
7. Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age. Alaggio R; Coffin CM; Weiss SW; Bridge JA; Issakov J; Oliveira AM; Folpe AL Am J Surg Pathol; 2009 May; 33(5):645-58. PubMed ID: 19194281 [TBL] [Abstract][Full Text] [Related]
8. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity. Coindre JM; Hostein I; Maire G; Derré J; Guillou L; Leroux A; Ghnassia JP; Collin F; Pedeutour F; Aurias A J Pathol; 2004 Jul; 203(3):822-30. PubMed ID: 15221942 [TBL] [Abstract][Full Text] [Related]
9. Liposarcomas with mixed well-differentiated and pleomorphic features: a clinicopathologic study of 12 cases. Boland JM; Weiss SW; Oliveira AM; Erickson-Johnson ML; Folpe AL Am J Surg Pathol; 2010 Jun; 34(6):837-43. PubMed ID: 20431480 [TBL] [Abstract][Full Text] [Related]
10. Correlation of histological grade of dedifferentiation with clinical outcome in 55 patients with dedifferentiated liposarcomas. Dantey K; Schoedel K; Yergiyev O; Bartlett D; Rao UNM Hum Pathol; 2017 Aug; 66():86-92. PubMed ID: 28300575 [TBL] [Abstract][Full Text] [Related]
11. Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry. Kammerer-Jacquet SF; Thierry S; Cabillic F; Lannes M; Burtin F; Henno S; Dugay F; Bouzillé G; Rioux-Leclercq N; Belaud-Rotureau MA; Stock N Hum Pathol; 2017 Jan; 59():34-40. PubMed ID: 27597521 [TBL] [Abstract][Full Text] [Related]
12. Primary cardiac dedifferentiated liposarcoma with homologous and heterologous differentiation: a case report. He D; Chen M; Chen H; Liao D; Wang X; Zhang Z; Zhang H Int J Clin Exp Pathol; 2015; 8(8):9662-6. PubMed ID: 26464734 [TBL] [Abstract][Full Text] [Related]
13. Fibrosarcoma-like lipomatous neoplasm: a reappraisal of so-called spindle cell liposarcoma defining a unique lipomatous tumor unrelated to other liposarcomas. Deyrup AT; Chibon F; Guillou L; Lagarde P; Coindre JM; Weiss SW Am J Surg Pathol; 2013 Sep; 37(9):1373-8. PubMed ID: 23887155 [TBL] [Abstract][Full Text] [Related]
14. Dedifferentiated Liposarcoma With Epithelioid/Epithelial Features. Makise N; Yoshida A; Komiyama M; Nakatani F; Yonemori K; Kawai A; Fukayama M; Hiraoka N Am J Surg Pathol; 2017 Nov; 41(11):1523-1531. PubMed ID: 28719466 [TBL] [Abstract][Full Text] [Related]
15. Pleomorphic liposarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic study of 32 additional cases. Wang L; Ren W; Zhou X; Sheng W; Wang J Pathol Int; 2013 Nov; 63(11):523-31. PubMed ID: 24274714 [TBL] [Abstract][Full Text] [Related]
16. Dedifferentiated liposarcoma with homologous lipoblastic differentiation: expanding the spectrum to include low-grade tumours. Liau JY; Lee JC; Wu CT; Kuo KT; Huang HY; Liang CW Histopathology; 2013 Apr; 62(5):702-10. PubMed ID: 23425231 [TBL] [Abstract][Full Text] [Related]
17. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR. Sirvent N; Coindre JM; Maire G; Hostein I; Keslair F; Guillou L; Ranchere-Vince D; Terrier P; Pedeutour F Am J Surg Pathol; 2007 Oct; 31(10):1476-89. PubMed ID: 17895748 [TBL] [Abstract][Full Text] [Related]
18. GLI1 Coamplification in Well-Differentiated/Dedifferentiated Liposarcomas: Clinicopathologic and Molecular Analysis of 92 Cases. Sharma AE; Dickson M; Singer S; Hameed MR; Agaram NP Mod Pathol; 2024 Jun; 37(6):100494. PubMed ID: 38621503 [TBL] [Abstract][Full Text] [Related]
19. Retroperitoneal dedifferentiated liposarcoma with osteosarcomatous components: a case report. Fujii T; Arai T; Sakon M; Sawano S; Momose Y; Ishii K; Miwa S Int J Clin Exp Pathol; 2013; 6(7):1427-31. PubMed ID: 23826426 [TBL] [Abstract][Full Text] [Related]
20. Atypical lipomatous tumor/well differentiated liposarcoma and related mimics with updates. When is molecular testing most cost-effective, necessary, and indicated? Kilpatrick SE Hum Pathol; 2024 May; 147():82-91. PubMed ID: 38135062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]